Latest Articles

Publication Date
All News Scientific
In recurrent endometrial cancer, BioNTech drug held off progression 8 months - Stock Titan

In recurrent endometrial cancer, BioNTech drug held off progression 8 months Stock Titan

Published: April 11, 2026, 11 a.m.
Read Full Article
Progesterone in MHT for Protection Against Endometrial Cancer - The Vajenda

Progesterone in MHT for Protection Against Endometrial Cancer The Vajenda

Published: April 11, 2026, 9:17 a.m.
Read Full Article
Australia's Cartherics expands agreement with Catalent to focus on cancer and endometriosis treatment - BioSpectrum Asia

Australia's Cartherics expands agreement with Catalent to focus on cancer and endometriosis treatment BioSpectrum Asia

Published: April 11, 2026, 7:52 a.m.
Read Full Article
Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as Highly Expressed, Clinically Relevant Target for Gynecologic Cancers - National Today

Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as Highly Expressed, Clinically Relevant Target for Gynecologic Cancers National Today

Published: April 10, 2026, 4:35 p.m.
Read Full Article
New Survey Data Exploring Patient Experiences with Endometrial Cancer Care Presented at 2026 Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer - StreetInsider

New Survey Data Exploring Patient Experiences with Endometrial Cancer Care Presented at 2026 Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer StreetInsider

Published: April 10, 2026, 11:01 a.m.
Read Full Article
New Survey Data Exploring Patient Experiences with Endometrial Cancer Care Presented at 2026 Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer - PR Newswire

New Survey Data Exploring Patient Experiences with Endometrial Cancer Care Presented at 2026 Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer PR Newswire

Published: April 10, 2026, 11 a.m.
Read Full Article
In ovarian cancer, one drug target towers up to 100-fold above rivals - Stock Titan

In ovarian cancer, one drug target towers up to 100-fold above rivals Stock Titan

Published: April 10, 2026, 11 a.m.
Read Full Article
Epigenetic Compound Library Screen Identifies Ibrutinib as an Inhibitor of Ovarian Clear Cell Carcinoma Viability.

Ovarian clear cell carcinoma (OCCC) is an endometriosis-associated ovarian cancer subtype. Somatic mutations in OCCC are reported in ARID1A, PIK3CA, and the TERT promoter (TERTp), as well as less commonly …

Published: April 10, 2026, midnight
Read Full Article
Bruton's tyrosine kinase drug repurposing ibrutinib ovarian clear cell carcinoma
Endometriosis and Endometrial Cancer-Association Between Biological Mechanisms and Its Clinical Implications.

Endometriosis and endometrial cancer are distinct gynecological conditions that share overlapping biological mechanisms with implications for clinical management. Endometriosis is a chronic, benign disorder characterized by the ectopic implantation of …

Published: April 10, 2026, midnight
Read Full Article
chronic inflammation endometrial cancer endometriosis estrogen dependence molecular pathways personalized medicine
Bridging the gap: Health advocates push for accessible, early-action cancer care - PressReader

Bridging the gap: Health advocates push for accessible, early-action cancer care PressReader

Published: April 9, 2026, 1:32 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!